ARCHIVES

FDA Approves Avastin For Recurrent NSCLC

This article is from The Cancer Letter archive.

Vol. 29 No. 10 | October 27, 2006

Download PDF Visit The Full Archive

Related Articles

Changes Put Pharma In Control Of Trials Traditionally Conducted By Academics.

March 26, 2010

NCI Tells How It Would Spend FY 1978 Research Money

June 25, 1976

Shift Of $6.5 Million From Contracts to Pay Core, P01s At Recommended Levels, Increase R01 Payline

June 27, 1980

Research Advocates Prepare to Face Republican-led Congress

December 19, 2014

Evidence Too Weak to Link Agent Orange, Cancer, IOM Says

March 22, 2002

In Brief: No More Shifts Planned For Treatment Programs; Groups Seek Surgeon, Radiologist Incentives

August 29, 1975